688580 Stock Overview
Engages in the research, development, production, and sale of medical devices in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Nanjing Vishee Medical Technology Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥32.02 |
| 52 Week High | CN¥46.04 |
| 52 Week Low | CN¥20.26 |
| Beta | 0.25 |
| 1 Month Change | 4.67% |
| 3 Month Change | 53.28% |
| 1 Year Change | -28.28% |
| 3 Year Change | -54.43% |
| 5 Year Change | n/a |
| Change since IPO | -75.23% |
Recent News & Updates
Nanjing Vishee Medical Technology (SHSE:688580) Will Want To Turn Around Its Return Trends
Dec 17
Earnings Troubles May Signal Larger Issues for Nanjing Vishee Medical Technology (SHSE:688580) Shareholders
Nov 01Nanjing Vishee Medical Technology Co., Ltd's (SHSE:688580) Shares Leap 35% Yet They're Still Not Telling The Full Story
Oct 07Recent updates
Nanjing Vishee Medical Technology (SHSE:688580) Will Want To Turn Around Its Return Trends
Dec 17Earnings Troubles May Signal Larger Issues for Nanjing Vishee Medical Technology (SHSE:688580) Shareholders
Nov 01Nanjing Vishee Medical Technology Co., Ltd's (SHSE:688580) Shares Leap 35% Yet They're Still Not Telling The Full Story
Oct 07Nanjing Vishee Medical Technology (SHSE:688580) Is Reinvesting At Lower Rates Of Return
Aug 23Investors Don't See Light At End Of Nanjing Vishee Medical Technology Co., Ltd's (SHSE:688580) Tunnel
Jun 06Solid Earnings May Not Tell The Whole Story For Nanjing Vishee Medical Technology (SHSE:688580)
May 02Nanjing Vishee Medical Technology Co., Ltd (SHSE:688580) Shares Fly 30% But Investors Aren't Buying For Growth
Mar 06Nanjing Vishee Medical Technology Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 29Shareholder Returns
| 688580 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -2.1% | -2.8% | -1.2% |
| 1Y | -28.3% | -9.2% | 11.8% |
Return vs Industry: 688580 underperformed the CN Medical Equipment industry which returned -9.2% over the past year.
Return vs Market: 688580 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 688580 volatility | |
|---|---|
| 688580 Average Weekly Movement | 9.7% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688580 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688580's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 701 | Zhiyu Wang | www.vishee.com |
Nanjing Vishee Medical Technology Co., Ltd engages in the research, development, production, and sale of medical devices in China. The company offers medical equipment, including magnetic stimulators, biostimulus feedback instruments and products, and neonatal EEG measuring instruments; medical consumables, such as disposable sterile vaginal electrodes, vaginal electrodes, rectal electrodes, pelvic floor muscle rehabilitation devices, and body surface electrodes for physiotherapy; non-medical equipment comprising pulse magnetic, pelvic, and postpartum recovery instruments; and disposable and dedicated pelvic floor training probes, as well as other probes for pelvic floor training. It serves pelvic floor and postpartum, mental psychology, neurological rehabilitation, and sports rehabilitation fields.
Nanjing Vishee Medical Technology Co., Ltd Fundamentals Summary
| 688580 fundamental statistics | |
|---|---|
| Market cap | CN¥3.04b |
| Earnings (TTM) | CN¥112.74m |
| Revenue (TTM) | CN¥422.21m |
27.0x
P/E Ratio7.2x
P/S RatioIs 688580 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688580 income statement (TTM) | |
|---|---|
| Revenue | CN¥422.21m |
| Cost of Revenue | CN¥120.08m |
| Gross Profit | CN¥302.13m |
| Other Expenses | CN¥189.38m |
| Earnings | CN¥112.74m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.19 |
| Gross Margin | 71.56% |
| Net Profit Margin | 26.70% |
| Debt/Equity Ratio | 0% |
How did 688580 perform over the long term?
See historical performance and comparisonDividends
3.4%
Current Dividend Yield91%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 04:21 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nanjing Vishee Medical Technology Co., Ltd is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xipeng Feng | China International Capital Corporation Limited |
| Yanyin Zhu | China International Capital Corporation Limited |
| Xiao Wei Lin | Everbright Securities Co. Ltd. |